C57BL/6 WT and TLR9-/- mice were immunized by nasal instillation with 10 μg LaAg, using PBS as vehicle. Animals in the control group received only PBS. Immunization was performed in two doses, with a 7 day interval between each dose. One week after the 2nd dose, each animal was infected in the right hind paw with 5×105 L. amazonensis promastigotes (Josefa strain). A. Lesion sizes were measured on the indicated days and expressed as the difference of thickness between non-infected and infected paws. B. Parasite load was measured after 166 days of infection and expressed as the mean number of parasites per paw (mean ± SD; n = 4–5) *P ≤ 0.05 ***P<0.001; **P<0.01. Results representative of two independent experiments.</p
<p>Golden hamsters (4–6 per group) were immunised with IN LaAg (•), IM LaAg (▴), or received PBS (□)...
Background: Previously, we demonstrated that unlike subcutaneous or intramuscular vaccination, intra...
<p>Mice (n = 8 per group) vaccinated with the LiPABP1 + LiPABP2 + LiPABP3 combined genetic vaccine (...
C57BL/6 WT and TLR9-/- mice were immunized by nasal instillation with 10 μg LaAg using PBS as vehicl...
<p>Golden hamsters (6–8 per group) were vaccinated with either 10 µg of LaAg intranasally (•) or 20 ...
<p>(<b>A</b>) Evolution of the size of footpad lesions of mice challenged with 10<sup>5</sup> metacy...
Mice were vaccinated with LaAg on days -14 and -7 before infection, as described. Controls received ...
C57BL/6 WT and TLR9-/- mice were infected in the right hind paw with 5×105 L. amazonensis promastigo...
C57BL/6 WT and TLR9-/- mice were infected in the right hind paw with 5×105 L. amazonensis promastigo...
<p>Lesion size represents the average difference between infected and contralateral non-infected hin...
Leishmania (L.) amazonensis is one of the etiological agents of cutaneous leishmaniasis (CL) in Braz...
<p>Mice were immunized three times subcutaneously with PBS or different strains of <i>L. lactis</i> ...
<p>BALB/c mice (3–5 per group) were inoculated three times with PBS (open bars) or SGS (closed bars)...
<p><b>(A)</b> Mice were immunized with PBS, SL3261 (vector), or SL3261/p1C3 (vaccine) via the intran...
<p>Groups of 5 BALB/c (open circles) or C57BL/6 (filled circles) mice were infected in one of the hi...
<p>Golden hamsters (4–6 per group) were immunised with IN LaAg (•), IM LaAg (▴), or received PBS (□)...
Background: Previously, we demonstrated that unlike subcutaneous or intramuscular vaccination, intra...
<p>Mice (n = 8 per group) vaccinated with the LiPABP1 + LiPABP2 + LiPABP3 combined genetic vaccine (...
C57BL/6 WT and TLR9-/- mice were immunized by nasal instillation with 10 μg LaAg using PBS as vehicl...
<p>Golden hamsters (6–8 per group) were vaccinated with either 10 µg of LaAg intranasally (•) or 20 ...
<p>(<b>A</b>) Evolution of the size of footpad lesions of mice challenged with 10<sup>5</sup> metacy...
Mice were vaccinated with LaAg on days -14 and -7 before infection, as described. Controls received ...
C57BL/6 WT and TLR9-/- mice were infected in the right hind paw with 5×105 L. amazonensis promastigo...
C57BL/6 WT and TLR9-/- mice were infected in the right hind paw with 5×105 L. amazonensis promastigo...
<p>Lesion size represents the average difference between infected and contralateral non-infected hin...
Leishmania (L.) amazonensis is one of the etiological agents of cutaneous leishmaniasis (CL) in Braz...
<p>Mice were immunized three times subcutaneously with PBS or different strains of <i>L. lactis</i> ...
<p>BALB/c mice (3–5 per group) were inoculated three times with PBS (open bars) or SGS (closed bars)...
<p><b>(A)</b> Mice were immunized with PBS, SL3261 (vector), or SL3261/p1C3 (vaccine) via the intran...
<p>Groups of 5 BALB/c (open circles) or C57BL/6 (filled circles) mice were infected in one of the hi...
<p>Golden hamsters (4–6 per group) were immunised with IN LaAg (•), IM LaAg (▴), or received PBS (□)...
Background: Previously, we demonstrated that unlike subcutaneous or intramuscular vaccination, intra...
<p>Mice (n = 8 per group) vaccinated with the LiPABP1 + LiPABP2 + LiPABP3 combined genetic vaccine (...